NorthRock Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,209
Closed -$941K 751
2025
Q3
$941K Sell
2,209
-25
-1% -$9.69K 0.02% 362
2025
Q2
$856K Buy
2,234
+89
+4% +$32.1K 0.02% 273
2025
Q1
$741K Buy
2,145
+143
+7% +$46K 0.02% 263
2024
Q4
$601K Sell
2,002
-426
-18% -$149K 0.02% 307
2024
Q3
$987K Buy
2,428
+64
+3% +$23.4K 0.03% 214
2024
Q2
$760K Buy
2,364
+450
+24% +$146K 0.03% 239
2024
Q1
$640K Buy
1,914
+49
+3% +$15K 0.02% 295
2023
Q4
$505K Buy
1,865
+740
+66% +$183K 0.02% 322
2023
Q3
$277K Buy
1,125
+137
+14% +$37.5K 0.03% 255
2023
Q2
$300K Sell
988
-147
-13% -$40.9K 0.03% 216
2023
Q1
$299K Sell
1,135
-234
-17% -$59.4K 0.03% 220
2022
Q4
$329K Buy
+1,369
New +$307K 0.04% 230

Other funds holding HCA

NorthRock Partners's HCA Position: Q4 2025 in Review

NorthRock Partners sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 2,209 shares — an estimated $941K sold.

NorthRock Partners first reported a position in HCA in Q4 2022 and held it in 12 quarters. The position peaked at $987K in Q3 2024. 1,395 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

  • NorthRock Partners reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 2,209 HCA Healthcare shares in Q4 2025, an estimated $941K.
  • NorthRock Partners first reported a position in HCA Healthcare in Q4 2022 and held it in 12 quarters.
  • NorthRock Partners's HCA Healthcare position peaked at $987K in Q3 2024.
  • 1,395 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.